Developing CBD therapeutics to FDA standards
ANANDA’s Nantheia™ Investigational Drugs are currently being evaluated in multiple FDA-approved clinical trials in PTSD, OUD, SAD and Pain.
Active R&D program focused on Developing New Formulations targeting new therapeutic indications, including rare diseases.
Home | Value Proposition